A Case of Vasculitis in Chronic Hepatitis C Patient Treated with Pegylated Interferon Alpha-2a and Ribavirin |
Youn Ho Kim , Woo Sik Han , Sun Jae Lee , Sung Nam Oh , Do Won Choi , Kwan Soo Byun , Jong Eun Yeon |
Department of Internal Medicine, Korea University Medical College, Guro Hospital, Seoul, Korea |
|
|
ABSTRACT |
|
There has been an increase in the number of patients treated with pegylated interferon (PEG-IFN) and ribavirin due to the better antiviral efficacy. The main serious adverse events of PEG-IFN plus ribavirin combination therapy are bone marrow suppression and hemolytic anemia. However, there are few reports of vasculitis occurring during PEG-IFN therapy. We describe a patient who developed vasculitis during the treatment of chronic hepatitis C with PEG-IFN and ribavirin. (Korean J Hepatol 2007;13:419-422) |
KeyWords:
Hepatitis C, chronic; Peginterferon alfa-2a; Vasculitis; Skin |
|
|